Researchers have identified over 5,700 new proteins in rice and are calling for a global effort to find the remaining missing proteins, in a new study co-authored by Macquarie University.
The international team of scientists from Australia, Iran and Japan say there’s an estimated 35,000 proteins encoded by the rice genome, and yet we still don’t have experimental evidence for 82 per cent of them.
This is important because rice is the major food source for more than half the world’s population, and in order for it to grow in warmer climates and with less water we will need to better understand rice at the molecular level. Continue reading The quest for the missing proteins in rice→
Dr Andrew Care from the Department of Molecular Sciences has been awarded a 2018 Early Career Fellowship from the Cancer Institute NSW.
Andrew’s fellowship will fund research looking at how biological nanoparticles can be used to better deliver anti-cancer drugs to destroy tumours.
Andrew and his team are re-engineering protein-based nanoparticles that are normally found in microorganisms, like bacteria. These re-engineered nanoparticles will be capable of carrying anti-cancer drugs to tumours inside the body. Continue reading Using nanoparticles to better target cancer tumours→
Scientists in Australia and California have worked out how to unboil an egg. It may sound like an odd discovery, but it’s changed the way scientists think about manipulating proteins, an industry worth AU$160 billion per year.
Flinders University Professor Colin Raston and his team have developed Vortex Fluid Technology – using mechanical energy, or spinning, to reverse the effects of thermal energy, or boiling.
The molecular process behind a killer hole-punch has been revealed through a unique combination of technology—which Monash University call their ‘21st Century microscope’.
He’s back in the lab, working to convert the rich supply of stem cells found in the nose into specialised products to repair nerve damage or replace nerve cells lost in disorders such as hearing loss, Alzheimer’s and Parkinson’s disease.
But that’s just the latest phase in the full and distinguished life of the 2010 winner of Australia’s Prime Minister’s Prize for Science, molecular biologist Prof John Shine.
In 2011, he is stepping down after more than 20 years as executive director of Sydney’s Garvan Institute of Medical Research which, under his guidance, has grown to a staff of more than 500, an annual budget of $50 million, and now boasts significant achievements in cancer, immunology, diabetes and obesity, osteoporosis and neuroscience. Continue reading Back to the future for father of biotechnology→
How do the power plants of the cell—the mitochondria—use their defence mechanisms to fight diseases such as Parkinson’s disease? This debilitating disorder is caused by an accumulation of proteins that have folded incorrectly.
The misfolded proteins then clump together and form sticky, cell-damaging deposits called plaques.
“We know that mitochondria are at the centre of the aging process,” says Prof Nick Hoogenraad, executive director of the La Trobe Institute for Molecular Science (LIMS). Nick and his team have found a mechanism mitochondria use to remove the plaques that are prone to form as we age.
Donor corneas conditioned with DNA before being transplanted into new eyes are already actively contributing to their own success in experimental animals such as sheep.
The DNA is inserted into the cells of the cornea after it has been harvested. Then, following implantation, it produces proteins that help overcome immunological rejection.
This is one of many strands of research aimed at increasing the success rates of corneal transplants and other eye disease treatments undertaken by Prof Keryn Williams at Flinders University. Continue reading Helping eyes to help themselves→
Each year we identify early-career scientists with a discovery and bring them to Melbourne for a communication boot camp. Here are some of their stories.
Imagine printing your own room lighting, lasers, or solar cells from inks you buy at the local newsagent. Jacek Jasieniak and colleagues at CSIRO, the University of Melbourne and the University of Padua in Italy, have developed liquid inks based on quantum dots that can be used to print such devices and in the first demonstration of their technology have produced tiny lasers. Quantum dots are made of semiconductor material grown as nanometre-sized crystals, around a millionth of a millimetre in diameter. The laser colour they produce can be selectively tuned by varying their size.
High tech cling wraps that ‘sieve out’ carbon dioxide from waste gases can help save the world, says Melbourne University chemical engineer, Colin Scholes who developed the technology. The membranes can be fitted to existing chimneys where they capture CO2 for removal and storage. Not only are the new membranes efficient, they are also relatively cheap to produce. They are already being tested on brown coal power stations in Victoria’s La Trobe Valley, Colin says. “We are hoping these membranes will cut emissions from power stations by up to 90 per cent.”
Queensland researchers believe future cancer drugs could be grown in sunflowers and ultimately delivered as a seed ‘pill’.
They’re a long way from that outcome. But, as they reported to the XVIII International Botanical Congress in Melbourne earlier this year, they have already shown that sunflowers make a precursor to cancer drugs as part of their defence against insect attack.
The precursor, a small ring-like protein fragment known as SFTI, has already shown potential as a cancer treatment. Until now, however, it has been considered too expensive to produce by conventional means. Continue reading Could we grow drugs using sunflowers?→
Hundreds of Aussie science achievements that you can share in speeches, posts and publications